Skip to main content
. 2022 Mar 30;13:822004. doi: 10.3389/fimmu.2022.822004

Table 6.

Cited References in cluster 15 of the overlay analysis of co-cited references and keywords.

Rank Reference Citations Author Year Type Journal IF JCR
1 CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors 57 Majzner Robbie G. 2019 Article Clinical Cancer Research 12.531 Q1
2 Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells 46 Du Hongwei 2019 Article Cancer Cell 31.743 Q1
3 B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma 17 Tang Xin 2019 Article Molecular Therapy: Oncolytics 7.200 Q4
4 B7-H3-redirected chimeric antigen receptor T cells target glioblastoma
and neurospheres
12 Nehama Dean 2019 Article EBioMedicine 8.143 Q2
5 Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature 11 Seaman Steven 2017 Article Cancer Cell 31.743 Q1

IF, impact factors; JCR, journal citation reports.